购物车
- 全部删除
您的购物车当前为空
Uprosertib hydrochloride
还可以产品编号 T15428Cas号 1047635-80-2
别名 GSK2141795 (hydrochloride)
Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).
Uprosertib hydrochloride
还可以产品编号 T15428 别名 GSK2141795 (hydrochloride)Cas号 1047635-80-2
Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 19,400 | 1-2周 | |
| 50 mg | ¥ 25,800 | 1-2周 | |
| 100 mg | ¥ 33,500 | 1-2周 |
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
联系我们获取更多批次信息
资源下载
产品介绍
生物活性
化学信息
| 产品描述 | Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively). |
| 靶点活性 | ROCK1:1570 nM, ROCK2:1850 nM, CDK7:2100 nM, Akt3:38 nM, Akt1:180 nM, Akt2:328 nM |
| 体外活性 | Protein targets that bind Uprosertib in the lysate display a dose-dependent reduction in binding to the kinobeads, while proteins unaffected by the drug display no reduction in binding. Uprosertib inhibits Akt1/2/3 (Kd: 16/49/5 nM, respectively) and it also potently inhibits only the PKC family members PRKACA and PRKACB as well as the cGMP-dependent protein kinase PRKG1 aqpart from the Akts[1]. |
| 别名 | GSK2141795 (hydrochloride) |
| 分子量 | 465.71 |
| 分子式 | C18H17Cl3F2N4O2 |
| CAS No. | 1047635-80-2 |
| 密度 | no data available |
储存&溶解度
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
计算器
体内实验配液计算器
请在以下方框中输入您的动物实验信息后点击计算，可以得到母液配置方法和体内配方的制备方法：
比如您的给药剂量是 10 mg/kg ，每只动物体重 20 g ，给药体积 100 μL ， 
剂量转换
对于不同动物的给药剂量换算，您也可以参考 更多
关键词
评论列表
预览
Related Tags: buy Uprosertib hydrochloride | purchase Uprosertib hydrochloride | Uprosertib hydrochloride cost | order Uprosertib hydrochloride | Uprosertib hydrochloride chemical structure | Uprosertib hydrochloride in vitro | Uprosertib hydrochloride formula | Uprosertib hydrochloride molecular weight
嗨！很高兴为您提供帮助！
评论内容